Janux Therapeutics Inc —— 财务报表 (NASDAQ:JANX) | MetaTrader

展开完整图表

新闻

Truist因竞争因素下调Janux Therapeutics目标价

Truist cuts Janux Therapeutics stock price target on competition

Janux therapeutics doses first participant in JANX011 phase 1 trial

Vir Biotechnology Stock: The Low-Down On The Readouts Ahead (NASDAQ:VIR)

Wall Street Analysts See a 319.23% Upside in Janux Therapeutics (JANX): Can the Stock Really Move This High?

Janux Therapeutics任命William Go为新任首席医疗官

Janux Therapeutics appoints William Go as new chief medical officer

Bristol-Myers Squibb: Solid Tumor Collaboration With Janux And Camzyos Expansion (BMY)

JANX Enters Global Oncology Collaboration With BMY, Stock Rises

Janux股价在与百时美施贵宝达成合作协议后上涨

Janux stock rises after Bristol Myers Squibb collaboration deal

Janux Therapeutics Strikes Bristol Myers Biotech Deal Worth $800 Million - Janux Therapeutics (NASDAQ:JANX)